10 Most Popular Funds in March 2017 (Taiwan Domiciled)

10 Most Searched for Taiwan Domiciled Funds by tw.morningstar.com users

Morningstar Editors 14 April, 2017 | 10:21
Facebook Twitter LinkedIn

 

1. ABITL Global High Yield Fund TA RMB
Morningstar Category: High Yield Bond - Other Hedged
Morningstar Rating (2017-03-31): Not Rated

2. Taishin High Dividend Yield Balanced Fund
Morningstar Category: TWD Moderate Allocation
Morningstar Rating (2017-03-31): Stars 5

3. Allianz Global Investors Target Income Fund B TWD
Morningstar Category: High Yield Bond - Other Hedged
Morningstar Rating (2017-03-31):Not Rated

4. ABITL Global High Yield Fund TA TWD
Morningstar Category: High Yield Bond - Other Hedged
Morningstar Rating (2017-03-31): Not Rated

5. UBS (TW) Bond Fund - Asian High Yield - B
Morningstar Category: Asia High Yield Bond
Morningstar Rating (2017-03-31): Stars 3

6. Yuanta Global ETFs Stable Fund of Funds
Morningstar Category: Global Large-Cap Blend Equity
Morningstar Rating(2017-03-31): Stars 4

7. Allianz Global Investors Taiwan Fund
Morningstar Category: Taiwan Small/Mid-Cap Equity
Morningstar Rating (2017-03-31): Stars 5

8. PineBridge Global Multi-Strategy High Yield Bond Fund B TWD
Morningstar Category: Global High Yield Bond
Morningstar Rating (2017-03-31): Stars 2

9. SinoPac CSI 300 Dividend Index Fund
Morningstar Category: China Equity - A Shares
Morningstar Rating (2017-03-31): Stars 4

10. Allianz Global Investors Global Biotech Fund TWD
Morningstar Category: Sector Equity Biotechnology
Morningstar Rating (2017-03-31): Stars 3

 

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

 

Facebook Twitter LinkedIn

About Author

Morningstar Editors  -

© Copyright 2022 Morningstar Asia Ltd. All rights reserved.

Terms of Use        Privacy Policy